Categoría: Geovanny Vicente

SALT LAKE CITY, Aug. 4, 2020 /PRNewswire/ — If you want an example of the power of network marketing—when its engine is a revolutionary product and its driver is an enthusiastic and able group of independent distributors—you need look no further than the USA launch of Healy World.

After a 2019 world tour to introduce «The Healy» to 44 other countries, Healy World launched sales in the USA on May 1, 2020, at a time when potential customers still were sequestered.

Many questioned the strategy of a German company launching a product in the USA when «Closed for Business» signs were posted in shop windows from Boston to Burbank.  But Healy customers were enthusiastic. So, Healy Members taught their organizations how to use videoconferencing and other online tools to generate May retail sales of more than $9 million.  And in June, as word of the benefits of Healy technology began to spread, sales went even higher!

«I’d like to take credit for the explosion in retail sales and Member sponsoring,» says Healy World CEO Andreas Kornberger, a recognized expert in retail consumerism, «but the fact is that the dramatic success of retail sales is largely the result of the commitment of our enthusiastic Members and their patience confronting the challenges created by a launch of this size in a business climate still staggering due to historic challenges.»

To be fair, Healy was doing what had never been done before during a time when many thought it couldn’t be done. The result was often frustrating for customers waiting to receive their Healys and Members working to build sales organizations. 

«We had enough product in the USA to support the launch we anticipated, but not nearly enough for the launch our Members gave us,» says COO Carsten Marx, «and supply chain challenges were exacerbated by recent restrictions of air transport of technologies such as the Healy.»

So, Healy World brought on staff and consultants to create systems responding to new transportation restrictions and speeding the throughput of getting the Healy to market. Because getting the Healy to people who need the benefits has been the mission of Healy from the beginning.

Healy Founder Marcus Schmieke says, «We chose network marketing as our distribution method because our goal is to provide the benefits of the Healy to as many people around the world as quickly as possible. Also, the Healy requires a degree of education to fully activate, and we recognize the power of Healy Members to demonstrate and to teach its performance.»

Progressing from the Entrepreneurial Phase to the Management Stage

Management consultants and educators have long warned of the challenges associated with recognizing and accommodating a company’s move from entrepreneurial development to management support and controls. And that transition—because it often is not recognized as essential or occurs too late—has been identified as the cause of failure in many technology companies.

And when a company sells and recruits so successfully as Healy and its Members, that transition comes sooner than late. Which is why Carston Marx reports, «As a result of such dramatic growth in sales, and so as more fully to support our customers and Members, we are transitioning corporate leadership to a more experienced management base.»

One of those changes was replacing Dirc Zahlmann with the consumer-specific knowledge and management-specific skill set of new CEO Andreas Kornberger.  (Additional international and regional developments are planned for the near future.)

«We have two motivating commitments,» CEO Andreas Kornberger explains. «The most important we share with our Members: to fulfill the Healy Mission to benefit as many customers as possible, as quickly as practical. The second is to do whatever is required to support the satisfaction of our customers and the success of our Members. Whatever is required to assure professional corporate management and integrity, we will continue to do. We act swiftly to correct inefficiencies or a lack of probity.»

Educating for Success

One of the ways Healy is pursuing excellence is by teaching Members to understand and explain the range of benefits associated with the Healy.

Martin Wittmann, CPO, explains, «The Healy is first and foremost a microcurrent device that is extraordinarily effective for treating local pain and muscle soreness.»

FDA 510(k) Clearance of The Healy

«We applied to the U.S. Food and Drug Administration,» Wittman continues, «and received clearance to market Healy as a Class II medical device for local relief of acute, chronic, and arthritis pain and muscle soreness due to overexertion. When used in accordance with its directions, Healy delivers safe levels of microcurrent therapy comparable to other pain-relieving devices on the market. Unlike some similar devices, its small size and smartphone-app controls mean it can be worn even while exercising, working, or participating in other everyday activities.»

Separate Frequency Benefits

Separate from the 510(k) clearance, the Healy also has wellness applications that use individualized frequencies delivered by extremely low levels of microcurrent to help balance the mind and body and relieve stress.

«These applications,» Wittman says, «are based on emerging science that indicates subtle changes in cell vitality can be affected by particular frequencies.  Clinical experience in other countries supports use of such frequencies, particularly in combination with goals and affirmations.»

Healy frequency applications are designed to affect the electrical fields in and around the body – a phenomenon for which the U.S. National Institutes for Health has accepted the term «Biofield»—which plays an organizing and communicating role for the entire organism. 

(The frequency applications available in the Healy are not part of the FDA-cleared medical device and do not provide medical advice; nor can they treat, cure, diagnose, prevent or mitigate disease.)

The Healy’s ability to provide superior and convenient pain relief, combined with its ability to deliver innovative frequency applications for improved vitality and stress relief, have motivated enthusiastic customer response in 45 countries around the world, and Healy is investing in infrastructure to continue to serve customers and support Members with the resources they and the Healy deserve.

For more information contact:
Healy World USA
244679@email4pr.com 
(801) 973-5046

 

View original content:http://www.prnewswire.com/news-releases/healy-world-activates-network-marketing-to-serve-45-countries-301105678.html

SOURCE Healy USA

JACKSONVILLE, Fla., Aug. 4, 2020 /PRNewswire/ — Special Counsel, the nation’s leading provider of end-to-end legal solutions, and part of the Adecco Group‘s U.S. Professional Recruitment and Solutions unit, today announced it will participate in Relativity‘s Aero UI Advanced Access Program (AAAP). As a part of the AAAP, Special Counsel customers will gain early access to the new Aero UI and will be able to provide feedback on the user experience prior to Relativity’s global release in Q3 2020.

The new Aero UI centers around a simply powerful mindset, taking the RelativityOne platform to the next level with a modernized look and a faster, more intuitive functionality. Through the AAAP, Special Counsel customers not only get a first look at the next-generation interface, but the opportunity to directly influence a world-class e-discovery solution to suit their real-world business needs.

«Our clients are tackling complex projects under tight deadlines every day, so we continuously look to connect them with industry-leading solutions that support their productivity, and ultimately their success,» said Roger Birong, Jr., Senior Vice President, Information Technology at Special Counsel. «We can’t wait for our clients to get their hands on the new Aero UI and experience the benefits of the streamlined platform.»

Special Counsel has a longstanding partnership with Relativity and was recently recognized as the first ever RelativityOne Certified Gold Partner for its work on two custom applications, DiscoverMobile and Theia.

«We’re already evolving our image analytics app Theia, which is based on Microsoft’s Artificial Intelligence platform, Cognitive Services, to take advantage of the new Aero interface. We look forward to developing other tools that complement Aero UI’s enhanced features,» added Birong.

For more information on Special Counsel or to learn about their custom legal solutions, visit specialcounsel.com.

About Special Counsel
At Special Counsel, we are a leading provider of legal consulting, attorney recruiting, legal talent, legal technology and eDiscovery solutions, with a growing international footprint. But there’s more to being a leader than having tremendous size and scale. Our strength comes from our ability to partner with clients to create solutions on a case-by-case basis. It comes from our gift for fostering, furthering and promoting the expertise of our people. And it comes from our commitment to doing business with transparency, flexibility and integrity. That’s what sets us apart. That’s what makes us Special. To learn how we can help you, visit specialcounsel.com.

Special Counsel is a proud part of the world’s leading HR solutions partner, the Adecco Group, serving as its legal solutions business unit.

View original content:http://www.prnewswire.com/news-releases/special-counsel-selected-as-an-advanced-access-partner-for-aero-ui-301105673.html

SOURCE Special Counsel

PHOENIX, Aug. 4, 2020 /PRNewswire-PRWeb/ — Lerner and Rowe Injury Attorneys is pleased to announce that their law firm is partnering with United Food Bank to host a FREE backpack giveaway on Friday, August 7, 2020 at Mesa Convention Center (263 N. Center Street, Mesa, AZ 85201) from 7:00 a.m. through 12:00 p.m. Lerner and Rowe is donating 750 backpacks stuffed with school supplies to be handed out by United Food Bank while supplies last. Limitations do apply. Only one (1) backpack per student who is 18 years old or younger. Students must also be present. The Phoenix law firm decided to host the backpack giveaway to help students prepare for the 2020-2021 school year.

The drive-thru will be clearly marked with United Food Bank staff providing further direction to assist with the flow of traffic. Families are asked not to exit their vehicle when it comes time to accept a backpack. Staff will place backpacks in vehicle trunks, truck beds, or side van doors.

«For 2020, our team continues to actively reinvent the ways we give back and support local communities. We know how much the COVID-19 pandemic has financially affected the lives of many families. As such, we are not cancelling our annual Phoenix backpack giveaway, but instead are excited to partner with United Food Bank to host a drive-thru event. It is our hope that some of the typical back-to-school expenses will be offset through this giveaway, as well as giving students the needed tools to help them succeed in the 2020-2021 school year,» said attorney Kevin Rowe.

For more information about the Phoenix Backpack Giveaway, please contact Cindy Ernst or Christa Luirette with Lerner and Rowe at (602) 977-1900.

More About United Food Bank

United Food Bank is a 501(c)(3) nonprofit organization that has been providing hunger relief to people in need in the East Valley and eastern Arizona for more than 35 years. We collect, acquire, store, and distribute food and related commodities to more than 220 partner agencies that serve more than 228,000 people in need across more than 19,500 square miles. In 2019, United Food Bank distributed almost 24 million pounds of food providing nearly 19.5 million meals to our neighbors in need. In response to the economic impact of COVID 19, the food bank projects it will distribute nearly 25 million pounds of food (30 million meals) this year. Visit them at UnitedFoodBank.org and connect on Twitter @unitedfoodbank.

More About Lerner and Rowe

Lerner and Rowe Injury Attorneys is a powerhouse law firm in representing personal injury clients. Attorneys Glen Lerner and Kevin Rowe have grown their law firm into one of the largest personal injury firms in the country, with over 50 attorneys and nearly 400 support employees located in Arizona, Indiana, Illinois, Nevada, California, Washington, Oregon, New Mexico, and Tennessee. The law firm’s continuous exalted levels of success can be attributed to the high levels of respect and dignity shown to victims and family members hurt in an accident.

For those injured outside one of the previously listed states, Lerner and Rowe has an established network of attorneys across the country, ready to help. The firm takes pride in nourishing these relationships as they know a personal injury attorney can make all the difference in obtaining fair compensation for the pain and suffering inflicted upon the victims of tortious conduct.

For more information about Lerner and Rowe Injury Attorneys in Phoenix, please call 602-977-1900. To connect with the law firm socially, follow Lerner and Rowe on Twitter and Instagram, or become a fan of its Facebook page. Also, be sure to visit lernerandrowegivesback.com to learn more about the many other community services that the lawyers and legal support team of Lerner and Rowe actively support.

###

 

SOURCE Lerner and Rowe Injury Attorneys

CRANFORD, N.J., Aug. 4, 2020 /PRNewswire/ — Citius Pharmaceuticals, Inc. («Citius») («Company») (NASDAQ: CTXR), a specialty pharmaceutical company focused on adjunctive cancer care and critical care drug products announced progress in the development of Mino-Wrap, a novel approach to reducing post-operative infections associated with surgical implants.

Mino-Wrap is a gel-containing minocycline and rifampin film that is used to wrap the tissue expander («TE») used in breast reconstructive surgeries.  In order to stimulate early consultation and potentially speed the development of Mino-Wrap, the company has submitted a briefing package to the FDA Division of Anti-Infective Products.  The briefing package contains information regarding pre-clinical data and a clinical development plan, along with questions for the FDA regarding safety and efficacy data that would be required to advance Mino-Wrap into clinical trials. The company will consider the feedback provided by the FDA in the development of the Pre-IND.  There is no set timeline for FDA to respond to a consultation package; however, based on pre-COVID-19 experience, we expect a response from FDA within 60 days.

Mino-Wrap also marks the second collaboration with MD Anderson Cancer Center («MDACC») who are the inventors of this novel approach to preventing post-mastectomy infections when tissue expanders are used. The Company is currently developing Mino-Lok®, an antibiotic lock treatment for catheter-related bloodstream infections (CRBSIs), in collaboration with MDACC. Mino-Lok is in phase 3 development.   

«The published rate of infection for tissue expanders used in breast reconstructive surgery is between 2.5 % and 24%, with an estimated mean at around 12% to 14%.  We believe Mino-Wrap has the potential to provide a significant reduction in the incidence of infection, sparing the patient the pain and discomfort of extended hospitalization and further aggressive and lengthy courses of antibiotics in an attempt to salvage the TEs. In many cases the TE is removed leading to a delay in lifesaving chemo-radiation therapy, which can be a devastating consequence for the patient,» said Myron Holubiak, President and CEO of Citius Pharmaceuticals. «We also are extremely honored to be working with the doctors and scientists at MD Anderson Cancer Center to develop another much-needed improvement in adjunctive cancer care. The early consultation with FDA allows for the identification of optimal strategies for our preclinical and clinical development programs.  We are pleased to be taking advantage of this collaborative approach with the agency.»

About Mino-Wrap

Mino-Wrap is a novel approach to reducing post-operative infections associated with surgical implants. Mino-Wrap is a liquefying gel-based wrap containing minocycline and rifampin for reducing tissue expander (TE) infections following breast reconstructive surgeries.  It is a laminate film comprised of porcine gelatin plasticized with glycerol.  Mino-Wrap also contains the antibiotics minocycline and rifampin to reduce bacterial bioburden on implantable devices preventing colonization over a sustained period of time.  In the setting of breast reconstruction, Mino-Wrap is designed to provide more durable antimicrobial protection of the implant-tissue interface than peri-operative irrigation with antibiotic solutions (the current standard of care).  Both porcine gelatin (and collagen) as well as the combination of minocycline and rifampin have long histories of successful medical use in implantable devices in multiple anatomical settings. 

About Tissue Expanders and Infection Risk

A common breast reconstruction technique is tissue expansion, which involves expansion of the breast skin and muscle using a temporary tissue expander. A tissue expander is an empty breast implant that is filled with normal saline over 6 to 8 weeks until it reaches the breast size that is desired. In this type of reconstruction, the surgeon will either make a pocket under a large muscle in the chest and place a tissue expander in that space or place the expander above the large muscle. About 4 to 8 weeks after the tissue expansion is finished, a second surgery is required to remove the tissue expander and insert the permanent breast implant. The patient receives either microvascular flap reconstruction, or the insertion of a permanent breast implant. Infection is one of the most common complications of tissue expanders and implants during breast reconstruction, with an infection rate ranging from 2.5 to 24 percent.

About MD Anderson Cancer Center

The University of Texas MD Anderson Cancer Center in Houston ranks as one of the world’s most respected centers focused on cancer patient care, research, education and prevention. The institution’s sole mission is to end cancer for patients and their families around the world. MD Anderson is one of only 45 comprehensive cancer centers designated by the National Cancer Institute (NCI). MD Anderson is ranked No.1 for cancer care in U.S. News & World Report’s «Best Hospital’s» survey. It has ranked as one of the nation’s top two hospitals since the survey began in 1990, and has ranked first for 11 of the past 14 years. MD Anderson receives a cancer center support grant from the NCI of the National Institutes of Health (P30 CA016672).

About Citius Pharmaceuticals, Inc.

Citius is a late-stage specialty pharmaceutical company dedicated to the development and commercialization of critical care products, with a focus on anti-infectives and cancer care. For more information, please visit www.citiuspharma.com.

About Mino-Lok®

Mino-Lok® is an antibiotic lock solution being developed as an adjunctive therapy in patients with central line-associated bloodstream infections (CLABSIs) or catheter-related bloodstream infections (CRBSIs). CLABSIs/CRBSIs are very serious, especially in cancer patients receiving therapy through central venous catheters (CVCs) and in hemodialysis patients, for whom venous access presents a challenge. There are currently no approved therapies for salvaging infected CVCs.

Safe Harbor

This press release may contain «forward-looking statements» within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934. Such statements are made based on our expectations and beliefs concerning future events impacting Citius. You can identify these statements by the fact that they use words such as «will,» «anticipate,» «estimate,» «expect,» «should,» and «may» and other words and terms of similar meaning or use of future dates. Forward-looking statements are based on management’s current expectations and are subject to risks and uncertainties that could negatively affect our business, operating results, financial condition, and stock price. Factors that could cause actual results to differ materially from those currently anticipated are: risks of FDA response to  our pre-IND briefing package for Mino-Wrap and, depending on the response, our ability to successfully undertake and complete clinical trials and the results from those trials; our need for substantial additional funds; the estimated markets for our product candidates, and the acceptance thereof by any market; risks associated with conducting trials for our product candidates, including our Phase III trial for Mino-Lok; risks relating to the results of research and development activities; risks associated with developing our product candidates, including that preclinical results may not be predictive of clinical results and our ability to file an IND for such candidates, including Mino-Wrap; uncertainties relating to preclinical and clinical testing; the early stage of products under development; risks related to our growth strategy; our ability to obtain, perform under, and maintain financing and strategic agreements and relationships; our ability to identify, acquire, close, and integrate product candidates and companies successfully and on a timely basis; our ability to attract, integrate, and retain key personnel; government regulation; patent and intellectual property matters; competition; as well as other risks described in our SEC filings. We expressly disclaim any obligation or undertaking to release publicly any updates or revisions to any forward-looking statements contained herein to reflect any change in our expectations or any changes in events, conditions, or circumstances on which any such statement is based, except as required by law.

Contact:
Andrew Scott
Vice President, Corporate Development
(O) 908-967-6677 x105
ascott@citiuspharma.com

 

View original content:http://www.prnewswire.com/news-releases/citius-submits-mino-wrap-briefing-package-to-fda-for-pre-ind-consult-301105369.html

SOURCE Citius Pharmaceuticals, Inc.

NEW YORK, Aug. 4, 2020 /PRNewswire-PRWeb/ — In 1978, the Airline Deregulation Act (ADA), in large part, was meant to reduce bureaucracy, equal the playing field for start-up airlines, and lower ticket prices for consumers. Today, most will agree, airfares are more affordable, which has resulted in more people flying than ever before. It should be emphasized that while the ADA liberated the airlines to run their companies based on market-driven decisions, it did not alter the FAA’s broad authority to regulate safety. Then why, after more than four months of pandemic health and financial destruction, don’t we have a consistent, straightforward air travel safety policy?

To answer this, ExpertFlyer.com went One-on-One with Airlines for America (A4A), a trade association and lobbying group that represents major North American airlines, and Consumer Reports’ aviation adviser William J. McGee to discuss what’s happening, and what should be happening, to protect air travelers and rebuild consumer confidence in the airline industry.

«What we have right now is the Wild West,» said William J. McGee during his podcast interview with ExpertFlyer. «Individual airlines have their own policies and the authority to change those policies day to day while at the same time creating obvious health concerns, and confusion, for consumers.» Even if you’re only looking at air travel purely from a dollars and cents – and admittedly cold – perspective, McGee says that not having any across-the-board health regulations is simply bad business. «It just doesn’t make sense, because until consumers are confident that it’s safe to fly and that the airlines and airports and everyone is doing everything they need to do, they’re not going to fly. At least not in the numbers that airlines want to see.»

But Rebecca Spicer, senior vice president of communications at A4A, explained that U.S. airlines have proactively taken extraordinary measures to protect passengers and employees, including mandatory face coverings, enhanced cleaning, and health acknowledgements.

«The intensive cleaning protocols that U.S. airlines have implemented include electrostatic cleaning and fogging procedures, for example, and the HEPA (High Efficiency Particulate Air) filters that our carriers use completely recycle the air in the passenger cabin within two or three minutes while filtering out 99.9 percent of airborne particles. And of course, we’re encouraging travelers to utilize mobile check-in on their smartphones,» she added.

In response, McGee agrees that HEPA filters are very good but warns consumers about how airlines are touting its use within their fleet. «Although every airline in the U.S. has aircraft with HEPA filters, not every aircraft operating on behalf of those airlines has them,» he said. McGee also added that the filters will not impact direct exposure to germs. «Experts I’ve spoken with said that having 10 HEPA filters in the cabin still can’t protect you if the person sitting next to you sneezes or coughs. Germs have to reach the filter before they reach you. So, we’re back to the basics – wearing a mask, washing hands, and maintaining social distancing.

«If you look at this in terms of what needs to be done, I think you can come up with a couple of quick bullet points,» says McGee. «Each one of those bullet points is problematic and each one comes with a lot of questions. I am not holding myself out by any means as an expert on pandemics. None of us are. What we’re saying is just as after 9/11, all the experts were put in a room and told to come up with something. That’s what we’re saying needs to be done now.

«In order to regain consumer confidence, there needs to be some level of health safety consistency across airlines, and aircraft, so consumers know they are getting at least a minimum standard of safety when they fly, regardless of the airline name or aircraft model,» said Chris Lopinto, president of ExpertFlyer.com.

To read more about this fascinating and important debate regarding government regulation of the airline industry and hear the entire interview with Bill McGee from Consumer Reports, visit ExpertFlyer’s blog.

About William J. McGee
William J. McGee is the Aviation and Travel Adviser for Consumer Reports Advocacy, and the former editor of Consumer Reports Travel Letter. In 2010, the U.S. Secretary of Transportation chose him as the lone consumer advocate on the Future of Aviation Advisory Committee, and he is regularly called upon to testify before the U.S. Congress and federal agencies as an expert witness on airline safety, aviation security, and consumer protection issues. Prior to becoming a journalist, McGee spent nearly seven years in airline flight operations management and is an FAA-licensed aircraft dispatcher. He is the author of the books Attention All Passengers and Half the Child.

About Airlines for America (A4A)
Airlines for America (A4A) members are Alaska Airlines, American Airlines, Atlas Air, Delta Air Lines, FedEx, Hawaiian Airlines, JetBlue Airways, Southwest Airlines, United Airlines and UPS. Air Canada is an associate member.

A4A advocates on behalf of the leading U.S. airlines, both passenger and cargo carriers. A4A works collaboratively with industry stakeholders, federal agencies, the Administration, Congress, labor and other groups to improve aviation for the traveling and shipping public.
For more information about the airline industry, visit our website airlines.org and our blog, A Better Flight Plan, at airlines.org/blog.

About ExpertFlyer.com
Each month, ExpertFlyer’s One-on-One blog goes face-to-face with the travel industry’s leading decision makers to discuss and address topics relevant to many of today’s business and frequent travelers.

ExpertFlyer.com was conceived and created by an eclectic team consisting of a veteran elite tier frequent flyer, an airline captain and corporate travel manager, and information technology professionals to deliver a 24/7 real time powerful air travel information service. The company provides its subscribers and corporate travel managers alike with a complete, concise and efficient way to access the ever-changing details of worldwide air travel information. For more information, please visit expertflyer.com.

Stuck in the middle seat again? Download the free Seat Alerts app from ExpertFlyer and get the window or aisle seat without hassle or frustration.

# # #

 

SOURCE ExpertFlyer